A phase 1 dose escalation, pharmacokinetic, and pharmacodynamic evaluation of eIF-4E antisense oligonucleotide LY2275796 in patients with advanced cancer (Q37282959)
Jump to navigation
Jump to search
scientific article published on 10 August 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 1 dose escalation, pharmacokinetic, and pharmacodynamic evaluation of eIF-4E antisense oligonucleotide LY2275796 in patients with advanced cancer |
scientific article published on 10 August 2011 |
Statements
1 reference
A phase 1 dose escalation, pharmacokinetic, and pharmacodynamic evaluation of eIF-4E antisense oligonucleotide LY2275796 in patients with advanced cancer (English)
1 reference
Razelle Kurzrock
1 reference
Funda Meric-Bernstam
1 reference
Aung Naing
1 reference
David S Hong
1 reference
Yun Oh
1 reference
Jennifer Wheler
1 reference
Les Brail
1 reference
Sophie Callies
1 reference
Valérie André
1 reference
Sunil K Kadam
1 reference
Aejaz Nasir
1 reference
Timothy R Holzer
1 reference
Mayer Fishman
1 reference
George Simon
1 reference
10 August 2011
1 reference
1 reference
6582-6591
1 reference
Identifiers
1 reference
1 reference
1 reference